Kiniksa Pharmaceuticals, Ltd.
Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
knsa · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 11 Wall Street analysts in the past 3 months
Buy
11 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$71.00
Consensus
$64.00
+30.5% upside
Low
$59.00
Median: $62 · Last Close: $49.04
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$64.00
30.5% upside
High Target
$71
44.8%
Low Target
$59
20.3%
Current Price
$49.04
as of today
Based on analyst price targets, the KNSA stock price prediction for the next 12 months ranges from $59 to $71. The consensus KNSA price forecast of $64.00 implies 30.5% upside from the current price of $49.04.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $46.59 | ↓ 5.00% |
1-day model range: $46.17–$47.01. Peak: $47.01 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $79 | +60.2% |
| 2028 | $107 | +118.2% |
| 2029 | $130 | +165.5% |
| 2030 | $147 | +200.0% |
| 2031 | — | +223.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KNSA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-29 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-29 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-04-29 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-04-29 | Citigroup | Maintains | Buy→Buy |
| 2026-04-28 | Jefferies | Maintains | Buy→Buy |
| 2026-04-16 | Wedbush | Maintains | Outperform→Outperform |
| 2026-02-25 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-02-25 | Wedbush | Maintains | Outperform→Outperform |
| 2026-01-13 | Wedbush | Maintains | Outperform→Outperform |
| 2025-10-29 | Goldman Sachs | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Kiniksa Pharmaceuticals, Ltd. (KNSA) stock. Of the recent 36 rating actions, 1 were upgrades and 0 were downgrades. 11 analysts currently cover KNSA.
Analyst Recommendation Trends
KNSA analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 6 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$939M
↓ 25.9% YoY
Revenue Next Year
$1.1B
↑ 19.9% YoY
EPS This Year
$1.37
EPS Next Year
$1.91
↑ 39.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast KNSA EPS of $1.37 for the current fiscal year, based on estimates from 4 analysts. The KNSA revenue forecast is $939M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The KNSA stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus KNSA price target is $64.00 (+30.5% upside), with an analyst consensus of Buy.
The KNSA short-term stock prediction for tomorrow is $46.59 (-5.00%). The KNSA stock price prediction for 2027 estimates an average of $79. The KNSA stock prediction for 2030 projects a range of $133–$162.
Kiniksa Pharmaceuticals, Ltd. trades on NASDAQ under the ticker KNSA. The KNSA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
KNSA forecast · 8 questionsAccording to 11 Wall Street analysts, the average 12-month KNSA price target is $64.00, with a high forecast of $71.00 and a low of $59.00. The median price target is shown in the chart above when available. This implies +30.5% potential upside from the current price of $49.04.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.